{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:29:36Z","timestamp":1779892176678,"version":"3.53.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27061-2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:59:25Z","timestamp":1764327565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive biomarkers validation of CD3+ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach"],"prefix":"10.1038","volume":"15","author":[{"given":"Diego","family":"Carbonell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Rodr\u00edguez-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"G\u00f3mez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"P\u00e9rez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Galayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Panadero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rufi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rodr\u00edguez-Barquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Domingo-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mu\u00f1oz-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipto","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"3","key":"27061_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.56875\/2589-0646.1026","volume":"15","author":"YM Vanegas","year":"2022","unstructured":"Vanegas, Y. M. et al. CAR-T cell therapies for B-cell lymphoid malignancies: identifying targets beyond CD19: identifying targets beyond CD19. Hematol. Oncol. Stem Cell. Ther. 15 (3), 81\u201393. https:\/\/doi.org\/10.56875\/2589-0646.1026 (2022).","journal-title":"Hematol. Oncol. Stem Cell. Ther."},{"issue":"11","key":"27061_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2174\/0113892010257212231001082741","volume":"25","author":"MZ Ong","year":"2024","unstructured":"Ong, M. Z. et al. FDA-approved CAR T-cell therapy: A decade of progress and challenges. Curr. Pharm. Biotechnol. 25 (11), 1377\u20131393. https:\/\/doi.org\/10.2174\/0113892010257212231001082741 (2024).","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"11","key":"27061_CR3","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/cancers16111987","volume":"16","author":"T Str\u00fc\u00dfmann","year":"2024","unstructured":"Str\u00fc\u00dfmann, T., Marks, R. & W\u00e4sch, R. Relapsed\/refractory diffuse large B-cell lymphoma: is there still a role for autologous stem cell transplantation in the CAR T-cell era? Cancers (Basel). 16 (11), 1987. https:\/\/doi.org\/10.3390\/cancers16111987 (2024).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"27061_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/ejh.14132","volume":"112","author":"S Gupta","year":"2024","unstructured":"Gupta, S., Kohorst, M. & Alkhateeb, H. B. Determinants of outcomes and advances in CD19-directed chimeric antigen receptor therapy for B-cell acute lymphoblastic leukemia. Eur. J. Haematol. 112 (1), 51\u201363. https:\/\/doi.org\/10.1111\/ejh.14132 (2024).","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"27061_CR5","doi-asserted-by":"publisher","first-page":"103828","DOI":"10.1016\/j.transci.2023.103828","volume":"62","author":"I Pessach","year":"2023","unstructured":"Pessach, I. & Nagler, A. Leukapheresis for CAR-T cell production and therapy. Transfus. Apher Sci. 62 (6), 103828. https:\/\/doi.org\/10.1016\/j.transci.2023.103828 (2023).","journal-title":"Transfus. Apher Sci."},{"issue":"5","key":"27061_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","volume":"2","author":"M Abou-El-Enein","year":"2021","unstructured":"Abou-El-Enein, M. et al. Scalable manufacturing of CAR T cells for cancer immunotherapy. Blood Cancer Discov. 2 (5), 408\u2013422. https:\/\/doi.org\/10.1158\/2643-3230.BCD-21-0084 (2021).","journal-title":"Blood Cancer Discov"},{"issue":"9","key":"27061_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jcyt.2022.05.003","volume":"24","author":"M Qayed","year":"2022","unstructured":"Qayed, M. et al. Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing. Cytotherapy 24 (9), 869\u2013878. https:\/\/doi.org\/10.1016\/j.jcyt.2022.05.003 (2022).","journal-title":"Cytotherapy"},{"issue":"5","key":"27061_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/trf.14003","volume":"57","author":"ES Allen","year":"2017","unstructured":"Allen, E. S. et al. Autologous lymphapheresis for the production of chimeric antigen receptor T cells. Transfusion 57 (5), 1133\u20131141. https:\/\/doi.org\/10.1111\/trf.14003 (2017).","journal-title":"Transfusion"},{"issue":"5","key":"27061_CR9","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/trf.15178","volume":"59","author":"SA Tuazon","year":"2019","unstructured":"Tuazon, S. A. et al. Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies. Transfusion 59 (5), 1773\u20131780. https:\/\/doi.org\/10.1111\/trf.15178 (2019).","journal-title":"Transfusion"},{"issue":"4","key":"27061_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12185-021-03191-x","volume":"114","author":"I Yamanaka","year":"2021","unstructured":"Yamanaka, I. et al. Optimization of lymphapheresis for manufacturing autologous CAR-T cells. Int. J. Hematol. 114 (4), 449\u2013458. https:\/\/doi.org\/10.1007\/s12185-021-03191-x (2021).","journal-title":"Int. J. Hematol."},{"issue":"3","key":"27061_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/vox.13394","volume":"118","author":"JA Pi\u00f1eyroa","year":"2023","unstructured":"Pi\u00f1eyroa, J. A. et al. Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing. Vox Sang. 118 (3), 217\u2013222. https:\/\/doi.org\/10.1111\/vox.13394 (2023).","journal-title":"Vox Sang"},{"issue":"4","key":"27061_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/trf.17765","volume":"64","author":"W Kitamura","year":"2024","unstructured":"Kitamura, W. et al. Collection efficiency and safety of large-volume leukapheresis for the manufacturing of tisagenlecleucel. Transfusion 64 (4), 674\u2013684. https:\/\/doi.org\/10.1111\/trf.17765 (2024).","journal-title":"Transfusion"},{"issue":"1","key":"27061_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/trf.15576","volume":"60","author":"EJ Yoon","year":"2020","unstructured":"Yoon, E. J. et al. Validation of simple prediction algorithms to consistently achieve CD3 + and postselection CD34 + targets with leukapheresis. Transfusion 60 (1), 133\u2013143. https:\/\/doi.org\/10.1111\/trf.15576 (2020).","journal-title":"Transfusion"},{"issue":"7","key":"27061_CR14","first-page":"365","volume":"28","author":"T Jo","year":"2022","unstructured":"Jo, T. et al. A clinically applicable prediction model to improve T cell collection in chimeric antigen receptor T cell therapy. Transpl. Cell. Ther. 28(7), 365 (2022).","journal-title":"Transpl. Cell. Ther."},{"issue":"3","key":"27061_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcyt.2022.10.012","volume":"25","author":"MA O\u2019Reilly","year":"2023","unstructured":"O\u2019Reilly, M. A. et al. A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture. Cytotherapy 25 (3), 323\u2013329. https:\/\/doi.org\/10.1016\/j.jcyt.2022.10.012 (2023).","journal-title":"Cytotherapy"},{"issue":"8","key":"27061_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jcyt.2023.04.008","volume":"25","author":"M Lehmann","year":"2023","unstructured":"Lehmann, M. & Bonig, H. Predicting chimeric antigen receptor apheresis process volume. Cytotherapy 25 (8), 900\u2013901. https:\/\/doi.org\/10.1016\/j.jcyt.2023.04.008 (2023).","journal-title":"Cytotherapy"},{"issue":"1","key":"27061_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41467-023-36126-7","volume":"14","author":"DKY Zhang","year":"2023","unstructured":"Zhang, D. K. Y. et al. Enhancing CAR-T cell functionality in a patient-specific manner. Nat. Commun. 14 (1), 506. https:\/\/doi.org\/10.1038\/s41467-023-36126-7 (2023).","journal-title":"Nat. Commun."},{"issue":"2","key":"27061_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1423-0410.2006.00796.x","volume":"91","author":"L Pierelli","year":"2006","unstructured":"Pierelli, L. et al. Accurate prediction of autologous stem cell apheresis yields using a double variable-dependent method assures systematic efficiency control of continuous flow collection procedures. Vox Sang. 91 (2), 126\u2013134. https:\/\/doi.org\/10.1111\/j.1423-0410.2006.00796.x (2006).","journal-title":"Vox Sang"},{"issue":"5","key":"27061_CR19","doi-asserted-by":"publisher","first-page":"103758","DOI":"10.1016\/j.transci.2023.103758","volume":"62","author":"YM Castillo-Aleman","year":"2023","unstructured":"Castillo-Aleman, Y. M., Ventura-Carmenate, Y. & Ann-Martinez, M. Collection efficiency in apheresis. Transfus. Apher Sci. 62 (5), 103758. https:\/\/doi.org\/10.1016\/j.transci.2023.103758 (2023).","journal-title":"Transfus. Apher Sci."},{"issue":"2","key":"27061_CR20","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler, S. B., Hidalgo, J. H. & Bloch, T. Prediction of blood volume in normal human adults. Surgery 51 (2), 224\u2013232 (1962).","journal-title":"Surgery"},{"issue":"2","key":"27061_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.transci.2012.06.009","volume":"47","author":"P Accorsi","year":"2012","unstructured":"Accorsi, P., Passeri, C. & Iacone, A. A multiple regression analysis on factors influencing Haematopoietic progenitor cell collection for autologous transplantation. Transfusion and apheresis science. Official J. World Apheresis Association : Official J. Eur. Soc. Haemapheresis. 47 (2), 223\u2013227. https:\/\/doi.org\/10.1016\/j.transci.2012.06.009 (2012).","journal-title":"Official J. World Apheresis Association : Official J. Eur. Soc. Haemapheresis"},{"key":"27061_CR22","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"27061_CR23","doi-asserted-by":"crossref","unstructured":"Chen, T., Guestrin, C. & XGBoost: A Scalable Tree Boosting System. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New York, NY, USA: ACM; (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"27061_CR24","unstructured":"Lundberg, S. & Lee, S-I. A unified approach to interpreting model predictions. In I. Guyon, U. V. Luxburg, S. Bengio, H. Wallach, R. Fergus, S. Vishwanathan, & R. Garnett (Eds.), Advances in Neural Information Processing Systems 30. ;4765\u20134774. (2017)."},{"issue":"8","key":"27061_CR25","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/trf.17030","volume":"62","author":"DC Harrer","year":"2022","unstructured":"Harrer, D. C. et al. Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients. Transfusion 62 (8), 1602\u20131611. https:\/\/doi.org\/10.1111\/trf.17030 (2022).","journal-title":"Transfusion"},{"issue":"6","key":"27061_CR26","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.jcyt.2016.03.028","volume":"18","author":"D Watson","year":"2016","unstructured":"Watson, D. et al. Initial comparisons of three apheresis platforms for supporting the collection of CD3 + cells for CAR-T production. Cytotherapy 18 (6), S11. https:\/\/doi.org\/10.1016\/j.jcyt.2016.03.028 (2016).","journal-title":"Cytotherapy"},{"issue":"2","key":"27061_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000528331","volume":"50","author":"JA Pi\u00f1eyroa","year":"2023","unstructured":"Pi\u00f1eyroa, J. A., Cid, J. & Lozano, M. Get off on the right foot: how to plan an efficient leukocytapheresis to collect T cells for CAR T-cell manufacturing. Transfus. Med. Hemother. 50 (2), 98\u2013104. https:\/\/doi.org\/10.1159\/000528331 (2023).","journal-title":"Transfus. Med. Hemother"},{"issue":"22","key":"27061_CR28","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1039\/d1ma00859e","volume":"2","author":"CJO Bacal","year":"2021","unstructured":"Bacal, C. J. O. et al. Blood apheresis technologies \u2013 a critical review on challenges towards efficient blood separation and treatment. Mater. Adv. 2 (22), 7210\u20137236. https:\/\/doi.org\/10.1039\/d1ma00859e (2021).","journal-title":"Mater. Adv."},{"issue":"1","key":"27061_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","volume":"394","author":"S Ng","year":"2023","unstructured":"Ng, S., Masarone, S., Watson, D. & Barnes, M. R. The benefits and pitfalls of machine learning for biomarker discovery. Cell. Tissue Res. 394 (1), 17\u201331. https:\/\/doi.org\/10.1007\/s00441-023-03816-z (2023).","journal-title":"Cell. Tissue Res."},{"issue":"6","key":"27061_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41431-023-01361-5","volume":"31","author":"RR Malinda","year":"2023","unstructured":"Malinda, R. R. Biological data studies, scale-up the potential with machine learning. Eur. J. Hum. Genet. 31 (6), 619\u2013620. https:\/\/doi.org\/10.1038\/s41431-023-01361-5 (2023).","journal-title":"Eur. J. Hum. Genet."},{"key":"27061_CR31","doi-asserted-by":"publisher","first-page":"833912","DOI":"10.3389\/fdgth.2022.833912","volume":"4","author":"L Faes","year":"2022","unstructured":"Faes, L. et al. Artificial intelligence and statistics: just the old wine in new wineskins? Front. Digit. Health. 4, 833912. https:\/\/doi.org\/10.3389\/fdgth.2022.833912 (2022).","journal-title":"Front. Digit. Health"},{"key":"27061_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/acg2.75","author":"M Paroder","year":"2020","unstructured":"Paroder, M., Le, N., Pham, H. P. & Thibodeaux, S. R. Important aspects of T-cell collection by apheresis for manufacturing chimeric antigen receptor T cells. Adv. Cell. Gene Ther. https:\/\/doi.org\/10.1002\/acg2.75 (2020).","journal-title":"Adv. Cell. Gene Ther."},{"issue":"10","key":"27061_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jtct.2023.07.002","volume":"29","author":"AS Kanate","year":"2023","unstructured":"Kanate, A. S. et al. Updated indications for immune effector cell therapy: 2023 guidelines from the American society for transplantation and cellular therapy. Transpl. Cell. Ther. 29 (10), 594\u2013597. https:\/\/doi.org\/10.1016\/j.jtct.2023.07.002 (2023).","journal-title":"Transpl. Cell. Ther."},{"issue":"2","key":"27061_CR34","doi-asserted-by":"publisher","first-page":"101557","DOI":"10.1016\/j.beha.2024.101557","volume":"37","author":"C Chabannon","year":"2024","unstructured":"Chabannon, C. et al. Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: collection of real-world data in the context of hematopoietic cellular therapies. Best Pract. Res. Clin. Haematol. 37 (2), 101557. https:\/\/doi.org\/10.1016\/j.beha.2024.101557 (2024).","journal-title":"Best Pract. Res. Clin. Haematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27061-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:59:26Z","timestamp":1764327566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27061-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27061"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27061-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with institutional and national ethical standards. The protocol was reviewed and approved by the Research Ethics Committee of Hospital General Universitario Gregorio Mara\u00f1\u00f3n (protocol name: LINFOR, contract number: 82\/25, institutional code: 71\/25, date of approval: March 3rd 2025), which granted an exemption from obtaining individual informed consent due to the retrospective nature of the analysis and the use of routinely collected clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"42774"}}